TGFB1 and neoplasm: We hypothesize this improved tumor control is driven by the enhanced persistence of the TGF-β expanded γδ T cells, as supported by peripheral blood analysis demonstrating higher γδ T cell percentages in the TGF-β group four days after initial infusion (Supplementary Figures 9A, B).